(CercleFinance.com) – Sanofi announces the appointment of Brian Foard, its country director in the United States, to head the global specialty medicine business entity, appointment with immediate effect, by which he becomes a member of the executive committee of the health group.
Brian Foard, who held the position of head of North America specialty medicine and country director in the United States, has assumed interim responsibility for the global specialty medicine entity since September 2023.
He has more than twenty years of experience in the field of specialized biopharma and was responsible for the successful launch of Dupixent in more than fifty countries for multiple indications and age groups, before taking up his position current.